Your browser doesn't support javascript.
loading
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.
Baratchian, Mehdi; Tiwari, Ritika; Khalighi, Sirvan; Chakravarthy, Ankur; Yuan, Wei; Berk, Michael; Li, Jianneng; Guerinot, Amy; de Bono, Johann; Makarov, Vladimir; Chan, Timothy A; Silverman, Robert H; Stark, George R; Varadan, Vinay; De Carvalho, Daniel D; Chakraborty, Abhishek A; Sharifi, Nima.
Afiliação
  • Baratchian M; Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Tiwari R; Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Khalighi S; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106.
  • Chakravarthy A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
  • Yuan W; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London SM2 5NG, United Kingdom.
  • Berk M; Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Li J; Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Guerinot A; Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • de Bono J; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London SM2 5NG, United Kingdom.
  • Makarov V; Center for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Chan TA; Center for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Silverman RH; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Stark GR; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
  • Varadan V; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106.
  • De Carvalho DD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
  • Chakraborty AA; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Sharifi N; Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Proc Natl Acad Sci U S A ; 119(21): e2114324119, 2022 05 24.
Article em En | MEDLINE | ID: mdl-35584120
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores de Andrógenos / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2022 Tipo de documento: Article